Jorge Mercado is a staff writer with the Business Times. His beats include technology, agriculture, cannabis, energy and the environment, and higher education.
People from the private and public sectors believe the newly renamed Vandenberg Space Force Base has the potential to shape the Central Coast economy, and on June 3, those leaders laid out the first phase of their plan. At the online event, REACH — the Regional Economic Action Coalition, a San Luis Obispo-based economic development Read More →
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Semtech Corp., a Camarillo semiconductor company specializing in Internet of Things applications, saw its income and revenue rise in the first quarter of fiscal year 2021-22, thanks in large part to growth in its wireless and sensing products market. Semtech saw revenue rise 28% year-over-year to $170.4 million, the company said when it released its Read More →
EEL Armor, a startup focused on creating a new and affordable lightweight armor meant to stop the penetration of bullets from assault rifles, won the 2021 New Venture Competition hosted by UC Santa Barbara’s Technology Management Program on May 20. EEL Armor also won the people’s choice award at the event, helping the company net Read More →
Thousand Oaks-based Amgen won approval from the U.S. Food and Drug Administration on May 28 for its latest oral drug treatment, Lumakras, potentially adding another huge market for one of the largest biotech firms in the world. According to the Wall Street Journal, Amgen will charge $17,900 a month for the drug and analyst think Read More →